Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to help surgeons alleviate pain and restore mobility for their patients. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. 

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

Visit our booth #212 and discover our comprehensive portfolio at OSET 2022 


Our Medical Education Sessions at OSET 2022, demonstrate our commitment to supporting physicians at every stage of their educational journey, across a range of specialties.

If you're attending OSET 2022, we invite you to join our Zimmer Biomet Institute medical education events at OSET 2022. Register now!

Wednesday, September 21st

Thursday, September 22nd

Friday, September 23rd

*Paid Zimmer Biomet Consultants. This material is intended for health care professionals. 

Important Note: All content herein is protected by copyright, trademarks and other intellectual property rights, as applicable, owned by or licensed to Zimmer Biomet or its affiliates unless otherwise indicated, and must not be redistributed, duplicated or disclosed, in whole or in part, without the express written consent of Zimmer Biomet. Distribution to any other recipient is prohibited.

For indications, contraindications, warnings, precautions, potential adverse effects and patient counseling information, see the package insert or contact your local representative; visit www.zimmerbiomet.com for additional product information.

Patients must have a compatible smartphone or internet access and a text-capable phone to use mymobility; not all smart-phone features are available on the web-based version. Not all patients are candidates for mymobility and surgeons should evaluate individually to determine which patients are appropriate for therapy at home. Tricera is a trademark of RELIGN Inc. ©2022 Zimmer Biomet